Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 ConferencePRNewsWire • 05/11/23
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 16, 2023PRNewsWire • 05/05/23
PAVmed Digital Health Subsidiary, Veris Health, Appoints Gary Manning as PresidentPRNewsWire • 04/25/23
PAVmed Digital Health Subsidiary, Veris Health, to Present Comprehensive Meta-analysis on Impact of Remote Patient Monitoring in Oncology at HIMSSPRNewsWire • 04/19/23
Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and CancerPRNewsWire • 03/31/23
PAVmed Inc. (PAVM) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 03/17/23
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial ResultsPRNewsWire • 03/14/23
PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform™ Goes LivePRNewsWire • 02/28/23
Ultrasound Sensor Specialist Novosound Inks Deal With Nasdaq-listed PAVmed Inc. to Advance Intravascular Imaging TechnologyBusiness Wire • 12/21/22
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care PlatformBusiness Wire • 12/15/22
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic IndustryBusiness Wire • 12/08/22
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer ResearchBusiness Wire • 12/01/22
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial ResultsBusiness Wire • 11/14/22